These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33370317)

  • 21. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer.
    Dufait I; Schwarze JK; Liechtenstein T; Leonard W; Jiang H; Escors D; De Ridder M; Breckpot K
    Oncotarget; 2015 May; 6(14):12369-82. PubMed ID: 25869209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells.
    Kunz D; Walker G; Eberhardt W; Messmer UK; Huwiler A; Pfeilschifter J
    J Clin Invest; 1997 Dec; 100(11):2800-9. PubMed ID: 9389745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway.
    Lin Q; Ren L; Jian M; Xu P; Li J; Zheng P; Feng Q; Yang L; Ji M; Wei Y; Xu J
    Cell Death Dis; 2019 Sep; 10(10):693. PubMed ID: 31534132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors.
    Coosemans A; Baert T; Ceusters J; Busschaert P; Landolfo C; Verschuere T; Van Rompuy AS; Vanderstichele A; Froyman W; Neven P; Van Calster B; Vergote I; Timmerman D
    Int J Gynecol Cancer; 2019 Nov; 29(9):1381-1388. PubMed ID: 31685557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differences in immune damage between patients with severe fever with thrombocytopenia syndrome and patients with tsutsugamushi disease].
    Hu L; Kong Q; Yue C; He L; Xia L; Li J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):947-952. PubMed ID: 32912408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principal component analysis of early immune cell dynamics during pembrolizumab treatment of advanced urothelial carcinoma.
    Teshima T; Kobayashi Y; Kawai T; Kushihara Y; Nagaoka K; Miyakawa J; Akiyama Y; Yamada Y; Sato Y; Yamada D; Tanaka N; Tsunoda T; Kume H; Kakimi K
    Oncol Lett; 2022 Aug; 24(2):265. PubMed ID: 35765279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients.
    Marini O; Spina C; Mimiola E; Cassaro A; Malerba G; Todeschini G; Perbellini O; Scupoli M; Carli G; Facchinelli D; Cassatella M; Scapini P; Tecchio C
    Oncotarget; 2016 May; 7(19):27676-88. PubMed ID: 27050283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-22 promotes the proliferation of cancer cells in smoking colorectal cancer patients.
    Song B; Ma Y; Liu X; Li W; Zhang J; Liu J; Han J
    Tumour Biol; 2016 Jan; 37(1):1349-56. PubMed ID: 26293897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-derived growth factor (subtype BB) is elevated in patients with colorectal carcinoma.
    Belizon A; Balik E; Horst PK; Shantha Kumara HM; Nasar A; Whelan RL
    Dis Colon Rectum; 2009 Jun; 52(6):1166-71. PubMed ID: 19581863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of PDGF expression in serum of colorectal carcinoma patients--correlation with Duke's classification. Can PDGF become a potential biomarker?
    Braicu C; Tudoran O; Balacescu L; Catana C; Neagoe E; Berindan-Neagoe I; Ionescu C
    Chirurgia (Bucur); 2013; 108(6):849-54. PubMed ID: 24331325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent accumulation of circulating monocytic myeloid-derived suppressor cells contributes to post-infectious immunosuppression in renal transplant recipients with bacterial infection: A pilot study.
    Jiang Y; Feng S; Ji J; Lin Z; Zhang X
    Transpl Immunol; 2018 Jun; 48():10-17. PubMed ID: 29477752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
    Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
    Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells.
    Wang J; Shirota Y; Bayik D; Shirota H; Tross D; Gulley JL; Wood LV; Berzofsky JA; Klinman DM
    J Immunol; 2015 May; 194(9):4215-21. PubMed ID: 25825448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis.
    Jiao Z; Hua S; Wang W; Wang H; Gao J; Wang X
    Scand J Rheumatol; 2013; 42(2):85-90. PubMed ID: 23126644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy.
    Ornstein MC; Diaz-Montero CM; Rayman P; Elson P; Haywood S; Finke JH; Kim JS; Pavicic PG; Lamenza M; Devonshire S; Dann P; Schach K; Stephenson A; Campbell S; Emamekhoo H; Ernstoff MS; Hoimes CJ; Gilligan TD; Rini BI; Garcia JA; Grivas P
    Urol Oncol; 2018 Sep; 36(9):405-412. PubMed ID: 29606341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade.
    Ouzounova M; Lee E; Piranlioglu R; El Andaloussi A; Kolhe R; Demirci MF; Marasco D; Asm I; Chadli A; Hassan KA; Thangaraju M; Zhou G; Arbab AS; Cowell JK; Korkaya H
    Nat Commun; 2017 Apr; 8():14979. PubMed ID: 28382931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer.
    Okła K; Czerwonka A; Wawruszak A; Bobiński M; Bilska M; Tarkowski R; Bednarek W; Wertel I; Kotarski J
    Front Immunol; 2019; 10():691. PubMed ID: 31001284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocytic myeloid-derived suppressor cells generated from rhesus macaque bone marrow enrich for regulatory T cells.
    Zahorchak AF; Perez-Gutierrez A; Ezzelarab MB; Thomson AW
    Cell Immunol; 2018 Jul; 329():50-55. PubMed ID: 29803290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.